COVID-19 TESTING AVAILABLE

COVID-19 TESTING AVAILABLE

* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 10,000 tests per day.

Total Reported: 1,200,000+

Turnaround

0.5 Days

NEWS & RESOURCES

Congrats Leah Roberts

Congratulations to our own Leah Roberts for making it to the final round of Women of the Year in Science, presented by Women in Technology

Read More »

Executive War College Conference

Ipsum Diagnostics LLC is attending the Executive War Conference in New Orleans this week! Ipsum Diagnostics is a CAP-accredited, independent national reference laboratory providing an

Read More »